Search This Blog

Wednesday, October 4, 2023

Biogen inc: RBC Capital reduces the target price from USD 357 to USD 351.

 maintains its outperform rating

https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.